Clinical Trials Logo

Clinical Trial Summary

This is phase III trial to evaluate whether edoxaban, a direct factor Xa inhibitor, is noninferior to warfarin in preventing worsening of chronic thromboembolic pulmonary hypertension (CTEPH).


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04730037
Study type Interventional
Source Kyushu University
Contact
Status Completed
Phase Phase 3
Start date March 23, 2021
Completion date June 27, 2023

See also
  Status Clinical Trial Phase
Not yet recruiting NCT05140525 - Effects of Combination Medical Therapy Followed by BPA on Right Ventricular-PA Coupling and Hemodynamics in CTEPH Phase 3
Recruiting NCT06105242 - Biological Sex and CTEPH-related RV Dysfunction and Recovery (BIOSPHeRe)
Completed NCT03083093 - CTEPH Identification an Standard Computerised Tomography Pulmonary Angiography in Pulmonary Embolism Patients
Completed NCT03245268 - International BPA Registry
Recruiting NCT02660463 - Prospective Registry to Evaluate the Effective Incidence of Chronic Thromboembolic Pulmonary Hypertension in Germany N/A
Completed NCT01393327 - Feasibility and Influence of Exercise Therapy on Oxygen Uptake and Right Heart Function in CTEPH Patients After PEA N/A
Recruiting NCT01672203 - Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Incidence in Patients With Central Versus Peripheral Embolism N/A
Completed NCT03953560 - Symptom-related Screening for Early Detection of CTEPH. N/A
Completed NCT02656238 - New International CTEPH Database
Recruiting NCT05480137 - OCT Evaluates the Effects of CTEPH Treated by Scoring Balloon N/A
Terminated NCT03273257 - Riociguat in Patients With Operable CTEPH Prior to Pulmonary Endarterectomy (PEA Bridging Study) Phase 2
Recruiting NCT05629052 - TrEatment Approach in the Multimodal Era Registry
Recruiting NCT04207593 - The Effect of Oxygen Therapy on 6MWD in PAH and CTEPH Patients With Hypoxemia Phase 2